| Reference |
|---|
Schnell A, Huang L, Regan B, Singh V, Vonficht D, Bollhagen A, et al. Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation. Nat Immunol. 2023;24:1908-1920 pubmed publisher |
Kim D, Kim S, Kang M, Yin Z, Min B. Cell type specific IL-27p28 (IL-30) deletion in mice uncovers an unexpected regulatory function of IL-30 in autoimmune inflammation. Sci Rep. 2023;13:1812 pubmed publisher |
Choi G, Park Y, Cho M, Moon H, Kim D, Kang C, et al. A critical role for Th17 cell-derived TGF-β1 in regulating the stability and pathogenicity of autoimmune Th17 cells. Exp Mol Med. 2021;53:993-1004 pubmed publisher |
Luo X, Zeng Q, Li Y, Tang Y, Liu W, Luo R. The Inhibition of Group II Innate Lymphoid Cell Response by IL-27 in Allergic Rhinitis. J Immunol Res. 2020;2020:6661524 pubmed publisher |
Zhang H, Madi A, Yosef N, Chihara N, Awasthi A, Pot C, et al. An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell Subsets. Cell Rep. 2020;33:108433 pubmed publisher |
Choi G, Na H, Kuen D, Kim B, Chung Y. Autocrine TGF-β1 Maintains the Stability of Foxp3+ Regulatory T Cells via IL-12Rβ2 Downregulation. Biomolecules. 2020;10: pubmed publisher |
Matsuda M, Doi K, Tsutsumi T, Inaba M, Hamaguchi J, Terada T, et al. Adoptive transfer of type 1 regulatory T cells suppressed the development of airway hyperresponsiveness in ovalbumin-induced airway inflammation model mice. J Pharmacol Sci. 2019;141:139-145 pubmed publisher |
Abdullah A, Maged M, Hairul Islam M I, Osama I A, Maha H, Manal A, et al. Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis. PLoS ONE. 2019;14:e0215981 pubmed publisher |
Nguyen Q, Jang E, Le H, Kim S, Kim D, Dvorina N, et al. IL-27 targets Foxp3+ Tregs to mediate antiinflammatory functions during experimental allergic airway inflammation. JCI Insight. 2019;4: pubmed publisher |
Aoki R, Aoki Yoshida A, Suzuki C, Takayama Y. Indole-3-Pyruvic Acid, an Aryl Hydrocarbon Receptor Activator, Suppresses Experimental Colitis in Mice. J Immunol. 2018;201:3683-3693 pubmed publisher |
Ting H, de Almeida Nagata D, Rasky A, Malinczak C, Maillard I, Schaller M, et al. Notch ligand Delta-like 4 induces epigenetic regulation of Treg cell differentiation and function in viral infection. Mucosal Immunol. 2018;11:1524-1536 pubmed publisher |
Bouchareychas L, Grössinger E, Kang M, Adamopoulos I. ??TCR regulates production of interleukin-27 by neutrophils and attenuates inflammatory arthritis. Sci Rep. 2018;8:7590 pubmed publisher |
Do J, Kim D, Kim S, Valentin Torres A, Dvorina N, Jang E, et al. Treg-specific IL-27R? deletion uncovers a key role for IL-27 in Treg function to control autoimmunity. Proc Natl Acad Sci U S A. 2017;114:10190-10195 pubmed publisher |
Carson W, Cavassani K, Soares E, Hirai S, Kittan N, Schaller M, et al. The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages. J Immunol. 2017;199:1865-1874 pubmed publisher |
Mufazalov I, Kuschmann J, Andruszewski D, Masri J, Gabriel L, Adams P, et al. Balanced Bcl-3 expression in murine CD4+ T cells is required for generation of encephalitogenic Th17 cells. Eur J Immunol. 2017;47:1335-1341 pubmed publisher |
Stier M, Goleniewska K, Cephus J, Newcomb D, Sherrill T, Boyd K, et al. STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection. J Immunol. 2017;199:510-519 pubmed publisher |
Pérez Cabezas B, Cecílio P, Robalo A, Silvestre R, Carrillo E, Moreno J, et al. Interleukin-27 Early Impacts Leishmania infantum Infection in Mice and Correlates with Active Visceral Disease in Humans. Front Immunol. 2016;7:478 pubmed |
Vijayan D, Mohd Redzwan N, Avery D, Wirasinha R, Brink R, Walters G, et al. IL-27 Directly Enhances Germinal Center B Cell Activity and Potentiates Lupus in Sanroque Mice. J Immunol. 2016;197:3008-3017 pubmed |
Howes A, Taubert C, Blankley S, Spink N, Wu X, Graham C, et al. Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages. J Immunol. 2016;197:2838-53 pubmed publisher |
Gao F, Yang Y, Feng X, Fan T, Jiang L, Guo R, et al. Interleukin-27 is elevated in sepsis-induced myocardial dysfunction and mediates inflammation. Cytokine. 2016;88:1-11 pubmed publisher |
Tang H, Zhang J, Sun X, Qian X, Zhang Y, Jin R. Thymic DCs derived IL-27 regulates the final maturation of CD4(+) SP thymocytes. Sci Rep. 2016;6:30448 pubmed publisher |
Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, et al. TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329 pubmed publisher |
Zhu C, Sakuishi K, Xiao S, Sun Z, Zaghouani S, Gu G, et al. An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction. Nat Commun. 2015;6:6072 pubmed publisher |
Neumann C, Heinrich F, Neumann K, Junghans V, Mashreghi M, Ahlers J, et al. Role of Blimp-1 in programing Th effector cells into IL-10 producers. J Exp Med. 2014;211:1807-19 pubmed publisher |
de Aquino M, Kapil P, Hinton D, Phares T, Puntambekar S, Savarin C, et al. IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination. J Immunol. 2014;193:285-94 pubmed publisher |
Zhu E, Wang X, Zheng B, Wang Q, Hao J, Chen S, et al. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting ROR?t and STAT3. J Immunol. 2014;192:5599-609 pubmed publisher |
Liu F, Kenngott E, Schröter M, Kühl A, Jennrich S, Watzlawick R, et al. Timed action of IL-27 protects from immunopathology while preserving defense in influenza. PLoS Pathog. 2014;10:e1004110 pubmed publisher |
Sutherland A, Joller N, Michaud M, Liu S, Kuchroo V, Grusby M. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet. J Immunol. 2013;190:3977-84 pubmed publisher |
Tormo A, Letellier M, Sharma M, Elson G, Crabé S, Gauchat J. IL-6 activates STAT5 in T cells. Cytokine. 2012;60:575-82 pubmed publisher |
Freeman B, Hammarlund E, Raué H, Slifka M. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci U S A. 2012;109:9971-6 pubmed publisher |
Rajaiah R, Puttabyatappa M, Polumuri S, Moudgil K. Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritis. J Biol Chem. 2011;286:2817-25 pubmed publisher |
Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol. 2010;84:12703-12 pubmed publisher |
Findlay E, Greig R, Stumhofer J, Hafalla J, de Souza J, Saris C, et al. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J Immunol. 2010;185:2482-92 pubmed publisher |
Pot C, Jin H, Awasthi A, Liu S, Lai C, Madan R, et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol. 2009;183:797-801 pubmed publisher |
Dibra D, Cutrera J, Xia X, Birkenbach M, Li S. Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance. Cancer Res. 2009;69:5505-13 pubmed publisher |
Miyazaki Y, Shimanoe Y, Wang S, Yoshida H. Amelioration of delayed-type hypersensitivity responses by IL-27 administration. Biochem Biophys Res Commun. 2008;373:397-402 pubmed publisher |
Guo B, Chang E, Cheng G. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest. 2008;118:1680-90 pubmed publisher |
Fitzgerald D, Zhang G, El Behi M, Fonseca Kelly Z, Li H, Yu S, et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol. 2007;8:1372-9 pubmed |
Fitzgerald D, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol. 2007;179:3268-75 pubmed |
